Computational Modeling of Drugs Against Alzheimer’s Disease: Neuromethods, cartea 203
Editat de Kunal Royen Limba Engleză Hardback – iul 2023
This second edition volume expands on the previous edition with updated descriptions on different computational methods encompassing ligand-based, structure-based, and combined approaches with their recent applications in anti-Alzheimer drug design. Different background topics like recent advancements in research on the development of novel therapies and their implications in the treatment of Alzheimer’s Disease (AD) have also been covered for completeness. Special topics like basic information science methods for insight into neurodegenerative pathogenesis, drug repositioning and network pharmacology, and online tools to predict ADMET behavior with reference to anti-Alzheimer drug development have also been included. In the Neuromethods series style, chapter include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Cutting-edge and thorough, Computational Modeling of Drugs Against Alzheimer’s Disease, Second Edition is a valuable resource for all researchers and scientists interested in learning more about this important and developing field.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 617.72 lei 38-44 zile | |
Springer – 10 aug 2018 | 617.72 lei 38-44 zile | |
Hardback (2) | 949.13 lei 6-8 săpt. | |
Springer – 29 sep 2017 | 949.13 lei 6-8 săpt. | |
Springer Us – iul 2023 | 1786.58 lei 6-8 săpt. |
Din seria Neuromethods
- 15% Preț: 640.64 lei
- 15% Preț: 646.03 lei
- 18% Preț: 958.31 lei
- 24% Preț: 852.88 lei
- 18% Preț: 925.68 lei
- 18% Preț: 927.84 lei
- 23% Preț: 1063.38 lei
- 23% Preț: 690.15 lei
- 20% Preț: 1252.02 lei
- 15% Preț: 633.64 lei
- 18% Preț: 928.27 lei
- 23% Preț: 705.38 lei
- 18% Preț: 945.44 lei
- 18% Preț: 937.17 lei
- 18% Preț: 940.23 lei
- 15% Preț: 643.98 lei
- 15% Preț: 627.93 lei
- 15% Preț: 631.11 lei
- Preț: 395.28 lei
- 19% Preț: 580.66 lei
- 19% Preț: 584.10 lei
- 19% Preț: 566.40 lei
- 15% Preț: 633.49 lei
- 15% Preț: 636.36 lei
- 18% Preț: 931.82 lei
- 15% Preț: 633.81 lei
- 15% Preț: 630.93 lei
- 15% Preț: 631.25 lei
- 15% Preț: 631.56 lei
- 15% Preț: 629.85 lei
- 18% Preț: 1009.38 lei
- 18% Preț: 935.50 lei
- 15% Preț: 636.36 lei
Preț: 1786.58 lei
Preț vechi: 2178.75 lei
-18% Nou
Puncte Express: 2680
Preț estimativ în valută:
341.95€ • 356.40$ • 284.66£
341.95€ • 356.40$ • 284.66£
Carte tipărită la comandă
Livrare economică 04-18 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781071633106
ISBN-10: 1071633104
Ilustrații: XVII, 493 p. 176 illus., 122 illus. in color. With online files/update.
Dimensiuni: 178 x 254 mm
Greutate: 1.1 kg
Ediția:Second Edition 2023
Editura: Springer Us
Colecția Humana
Seria Neuromethods
Locul publicării:New York, NY, United States
ISBN-10: 1071633104
Ilustrații: XVII, 493 p. 176 illus., 122 illus. in color. With online files/update.
Dimensiuni: 178 x 254 mm
Greutate: 1.1 kg
Ediția:Second Edition 2023
Editura: Springer Us
Colecția Humana
Seria Neuromethods
Locul publicării:New York, NY, United States
Cuprins
Recent Progress in the Treatment Strategies of Alzheimer’s Disease.- Understanding the Mechanisms of Amyloid Beta (Aβ) Aggregation by Computational Modeling.- Recent Advances in Computational Modeling of BACE1 Inhibitors as Anti-Alzheimer Agents.- Modeling of BACE-1 Inhibitors as Anti-Alzheimer’s Agents.- Computational Modeling of Kinase Inhibitors as Anti-Alzheimer Agents.- Computer-Assisted Drug Design: A Toolbox for Novel Tau Kinase Inhibitors and Its Implications in Alzheimer’s Disease.- Computational Modeling Approaches in Search of Anti-Alzheimer Agents: Case Studies of Phosphodiesterase Inhibitors.- Recent Advances in Computational Modeling of Multi-Targeting Inhibitors as Anti-Alzheimer Agents.- Computational Modeling of PET and SPECT Imaging Agents as Diagnostics for Alzheimer’s Disease.- Computational Modeling of DYRK1A Inhibitors as Potential Anti-Alzheimer Agents.- Computational Modeling of MAO Inhibitors as Anti-Alzheimer Agents.- Computational Modeling of Phosphodiesterase Inhibitors as Anti-Alzheimer Agents.- Computational Methods for the Design and Development of Glutaminyl Cyclase Inhibitors in Alzheimer’s Disease.- Basic Information Science Methods for Insight into Neurodegenerative Pathogenesis.- Network Pharmacology for Drug Repositioning in Anti-Alzheimer's Drug Development.- Web Services for the Prediction of ADMET Parameters Relevant to the Design of Neuroprotective Drugs.
Textul de pe ultima copertă
This second edition volume expands on the previous edition with updated descriptions on different computational methods encompassing ligand-based, structure-based, and combined approaches with their recent applications in anti-Alzheimer drug design. Different background topics like recent advancements in research on the development of novel therapies and their implications in the treatment of Alzheimer’s Disease (AD) have also been covered for completeness. Special topics like basic information science methods for insight into neurodegenerative pathogenesis, drug repositioning and network pharmacology, and online tools to predict ADMET behavior with reference to anti-Alzheimer drug development have also been included. In the Neuromethods series style, chapter include the kind of detail and key advice from the specialists needed to get successful results in your laboratory.
Cutting-edge and thorough, Computational Modeling of Drugs Against Alzheimer’s Disease, Second Edition is a valuable resource for all researchers and scientists interested in learning more about this important and developing field.
Caracteristici
Includes cutting-edge methods and protocols Provides step-by-step detail essential for reproducible results Contains key notes and implementation advice from the experts
Notă biografică
Dr. Kunal Roy is a Professor in the Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India. He has been a recipient of Commonwealth Academic Staff Fellowship (University of Manchester, 2007) and Marie Curie International Fellowship (University of Manchester, 2013). The field of his research interest is QSAR and Molecular Modeling with application in Drug Design and Ectoxicological Modeling. Dr. Roy has published more than 250 research papers in refereed journals (current SCOPUS h index 35). He has also coauthored two QSAR related books, edited two QSAR books and published ten book chapters. Dr. Roy serves in different capacities in the Editorial Boards of several International Journals.